July 2 (Reuters) - Lipidor AB LIPI.ST :
* LIPIDOR AB LICENCE AGREEMENT GRANTS MENARINI GROUP, RELIFE
SRL,EXCLUSIVE RIGHTS TO REGISTER, PROMOTE, DISTRIBUTE,MARKET
2NEW PSORIASIS DRUG CANDIDATES
* LIPIDOR AB - TOTAL POTENTIAL VALUE OF THIS AGREEMENT IS UP
TO
MEUR 70
* LIPIDOR AB- WILL BE ELIGIBLE TO RECEIVE MILESTONE PAYMENTS
OF UP
TO MEUR 19 AND A VOLUME-BASED ROYALTY PLAN LEADING UP TO TEENS
DIGIT VALUES ON SALES
* LIPIDOR AB LIPI.ST - RESULTS FROM PHASE III STUDY OF
THIS
SECOND CANDIDATE, CURRENTLY IN ITS INITIAL STAGES, ARE EXPECTED
FOR FIRST HALF OF 2022
* LIPIDOR AB LIPI.ST - LIPIDOR'S PARTNER AURENA
LABORATORIES
WILL BE RESPONSIBLE FOR COMMERCIAL PRODUCTION OF PRODUCTS
Source text for Eikon: ID:nWkr4RssbY
Further company coverage: LIPI.ST
((Reuters.Briefs@thomsonreuters.com;))